The synthesis of two novel 2-methylchromone-7-O-rutinosides, whose synthetic precursors and themselves in vitro biological activities have been investigated based on the cytotoxcity against several human tumor cell lines, was reported. The synthesis features early-stage assembly of the acidic labile glycosidic bond between sugar and 2-methylchromone aglycon under a phase transfer catalyzed glycosidation condition, whereas all the other standard glycosylation conditions specific to a wide array of rutinosyl donors bearing different anomeric leaving groups (e.g., SPh, OC(NH)CCl3, Br, OH groups) failed to furnish any detectable products.